• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在英格兰扩大乳腺癌筛查年龄范围:评估随机分组可行性和可接受性的试点研究。

Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization.

机构信息

Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford OX3 7LF.

出版信息

J Med Screen. 2011;18(2):96-102. doi: 10.1258/jms.2011.011065.

DOI:10.1258/jms.2011.011065
PMID:21852703
Abstract

OBJECTIVE

To assess the feasibility and acceptability of randomizing the phased introduction of the extension of the invited age range in the National Health Service (NHS) Breast Screening Programme in England from 50-70 to 47-73 years.

SETTING

Six volunteer breast screening units (BSUs) in England.

METHODS

Cluster-randomized trial of invitation versus no invitation for breast screening.

STUDY PARTICIPANTS

women aged 47-49 and 71-73 years in screening batches randomized between 1 June 2009 and 31 May 2010.

OUTCOMES

workload, screening uptake among women invited, self-referrals among women not invited, and screening outcomes among women invited.

RESULTS

A total of 312 screening batches (clusters) were randomized including 60,708 women. Screening uptake was 63% in women aged 47-49 and 62% in women aged 71-73. Those who attended screening in the younger age group were more likely to be recalled for assessment than older attendees (7.5% vs. 3.0%) but less likely to be diagnosed with breast cancer (0.5% vs. 1.1%). Among women not invited, 0.2% of those aged 47-49 and 6.8% of those aged 71-73 self-referred for screening. Despite the extra workload BSUs largely coped although there was some slippage in round lengths and other targets.

CONCLUSION

No major problems of feasibility or acceptability of randomization were found. This pilot study has informed the randomized phasing-in of the age extension across the whole of England.

摘要

目的

评估在英格兰国民保健署(NHS)乳房筛查计划中将邀请年龄范围从 50-70 岁扩展到 47-73 岁分阶段引入的可行性和可接受性。

设置

英格兰六个志愿乳房筛查单位(BSU)。

方法

采用邀请与不邀请进行乳房筛查的聚类随机试验。

研究对象

2009 年 6 月 1 日至 2010 年 5 月 31 日期间随机分配到筛查批次的 47-49 岁和 71-73 岁的女性。

结果

共随机分配了 312 个筛查批次(聚类),包括 60708 名女性。47-49 岁女性的筛查参与率为 63%,71-73 岁女性的筛查参与率为 62%。在年龄较小的组中参加筛查的女性比年龄较大的女性更有可能被召回评估(7.5%比 3.0%),但被诊断患有乳腺癌的可能性较小(0.5%比 1.1%)。在未被邀请的女性中,47-49 岁的女性中有 0.2%,71-73 岁的女性中有 6.8%自我推荐进行筛查。尽管工作量增加,但 BSUs 基本上能够应对,尽管在轮次长度和其他目标方面存在一些拖延。

结论

随机分组没有发现重大的可行性或可接受性问题。这项试点研究为英格兰全国范围内年龄扩展的分阶段实施提供了信息。

相似文献

1
Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization.在英格兰扩大乳腺癌筛查年龄范围:评估随机分组可行性和可接受性的试点研究。
J Med Screen. 2011;18(2):96-102. doi: 10.1258/jms.2011.011065.
2
Comparison of breast and bowel cancer screening uptake patterns in a common cohort of South Asian women in England.比较英格兰南亚裔妇女中常见队列的乳腺癌和肠癌筛查参与模式。
BMC Health Serv Res. 2010 Apr 27;10:103. doi: 10.1186/1472-6963-10-103.
3
Effect on attendance at breast cancer screening of adding a self administered questionnaire to the usual invitation to breast screening in southern England.在英格兰南部,在常规乳腺癌筛查邀请中增加一份自我填写问卷对乳腺癌筛查参与率的影响。
J Epidemiol Community Health. 1998 Feb;52(2):116-9. doi: 10.1136/jech.52.2.116.
4
Response by women aged 65-79 to invitation for screening for breast cancer by mammography: a pilot study.65至79岁女性对乳腺钼靶筛查邀请的反应:一项试点研究。
BMJ. 1990 Dec 8;301(6764):1314-6. doi: 10.1136/bmj.301.6764.1314.
5
Response of women aged 65-74 to invitation for screening for breast cancer by mammography: a pilot study in London, UK.65至74岁女性对乳房X光摄影筛查乳腺癌邀请的反应:英国伦敦的一项试点研究
J Epidemiol Community Health. 1996 Feb;50(1):77-80. doi: 10.1136/jech.50.1.77.
6
Mammography screening in the county of Fyn. November 1993-December 1999.菲英岛县的乳腺钼靶筛查。1993年11月 - 1999年12月。
APMIS Suppl. 2003(110):1-33.
7
Screening outcomes in women over age 70 who self-refer in the NHSBSP in England.英格兰 NHSBSP 中 70 岁以上女性自我转诊的筛查结果。
J Med Screen. 2011;18(2):91-5. doi: 10.1258/jms.2011.010134.
8
Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCT.健康筛查门诊减少 NHS 员工旷工和出勤主义:eTHOS 一项试点 RCT。
Health Soc Care Deliv Res. 2024 Aug;12(23):1-105. doi: 10.3310/KDST3869.
9
Evaluation of extension of breast screening to women aged 65-70 in England using screening performance measures.使用筛查性能指标评估在英格兰将乳腺癌筛查扩展至65 - 70岁女性的情况。
Br J Cancer. 2009 Apr 7;100(7):1043-7. doi: 10.1038/sj.bjc.6604981. Epub 2009 Mar 10.
10
Slippage in the NHS breast screening programme: an assessment of whether a three year screening round is being achieved.英国国家医疗服务体系乳房筛查计划中的筛查遗漏情况:对是否实现三年一轮筛查的评估。
J Med Screen. 1998;5(2):88-91. doi: 10.1136/jms.5.2.88.

引用本文的文献

1
The clinical and molecular landscape of breast cancer in women of African and South Asian ancestry.非洲和南亚裔女性乳腺癌的临床与分子概况。
Nat Commun. 2025 May 20;16(1):4237. doi: 10.1038/s41467-025-59144-z.
2
Mammographic surveillance after breast cancer.乳腺癌后的乳腺 X 线摄影监测。
Br J Radiol. 2024 May 7;97(1157):882-885. doi: 10.1093/bjr/tqae043.
3
General practitioners' views and experiences of communicating with older people about cancer screening: a qualitative study.全科医生对老年人进行癌症筛查沟通的看法和经验:一项定性研究。
Fam Pract. 2024 Aug 14;41(4):543-553. doi: 10.1093/fampra/cmac126.
4
Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting.在英国实施风险分层乳腺筛查:一次议程设定会议
Cancers (Basel). 2022 Sep 24;14(19):4636. doi: 10.3390/cancers14194636.
5
Impact of the third national 'Be Clear on Cancer' Breast Cancer in Women over 70 Campaign on general practitioner attendance and referral, diagnosis rates and prevalence awareness.“三早行动——全国 70 岁以上女性乳腺癌筛查”对全科医生就诊和转诊、诊断率及知晓率的影响。
Eur J Cancer Care (Engl). 2022 May;31(3):e13583. doi: 10.1111/ecc.13583. Epub 2022 Apr 5.
6
Ethnicity and the surgical management of early invasive breast cancer in over 164 000 women.种族与超过 164000 例早期浸润性乳腺癌的外科治疗。
Br J Surg. 2021 May 27;108(5):528-533. doi: 10.1002/bjs.11865.
7
Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.从 40 岁开始每年进行乳腺 X 线筛查以降低女性乳腺癌死亡率:英国年龄 RCT 的长期随访。
Health Technol Assess. 2020 Oct;24(55):1-24. doi: 10.3310/hta24550.
8
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial.40 岁开始进行乳腺 X 线筛查对乳腺癌死亡率的影响(英国年龄试验):一项随机对照试验的最终结果。
Lancet Oncol. 2020 Sep;21(9):1165-1172. doi: 10.1016/S1470-2045(20)30398-3. Epub 2020 Aug 12.
9
A review of the PERFORMS scheme in breast screening.乳腺筛查中PERFORMS方案的综述。
Br J Radiol. 2020 Aug;93(1112):20190908. doi: 10.1259/bjr.20190908. Epub 2020 Jun 12.
10
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting.45-49 岁时每年进行乳房 X 光造影检查,50-69 岁时每两年进行乳房 X 光造影检查:在有组织的筛查环境中比较效能指标。
Eur Radiol. 2019 Oct;29(10):5517-5527. doi: 10.1007/s00330-019-06050-w. Epub 2019 Mar 18.